Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Apr;41(4):844–846. doi: 10.1128/aac.41.4.844

High incidence of erythromycin-resistant streptococci in Taiwan.

J J Wu 1, K Y Lin 1, P R Hsueh 1, J W Liu 1, H I Pan 1, S M Sheu 1
PMCID: PMC163807  PMID: 9087502

Abstract

The activities of nine antimicrobial agents against 247 isolates of group B, C, F, and G streptococci and viridans group streptococci were studied by the broth microdilution method. Erythromycin resistance was found in 29.7, 41.7, 81.8, 23.5, and 53.3% of the strains of group B, C, F, and G streptococci and viridans group streptococci tested, respectively. Macrolides are not considered an optimal alternative to penicillin in the treatment of streptococcal infections, at least empirically, in Taiwan.

Full Text

The Full Text of this article is available as a PDF (151.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcaide F., Liñares J., Pallares R., Carratala J., Benitez M. A., Gudiol F., Martin R. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother. 1995 Oct;39(10):2243–2247. doi: 10.1128/aac.39.10.2243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berkowitz K., Regan J. A., Greenberg E. Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol. 1990 Jan;28(1):5–7. doi: 10.1128/jcm.28.1.5-7.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coonan K. M., Kaplan E. L. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J. 1994 Jul;13(7):630–635. doi: 10.1097/00006454-199407000-00009. [DOI] [PubMed] [Google Scholar]
  4. Doern G. V., Ferraro M. J., Brueggemann A. B., Ruoff K. L. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother. 1996 Apr;40(4):891–894. doi: 10.1128/aac.40.4.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gardner S. E., Yow M. D., Leeds L. J., Thompson P. K., Mason E. O., Jr, Clark D. J. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol. 1979 Dec 15;135(8):1062–1065. doi: 10.1016/0002-9378(79)90737-3. [DOI] [PubMed] [Google Scholar]
  6. Hsueh P. R., Chen H. M., Huang A. H., Wu J. J. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother. 1995 Oct;39(10):2239–2242. doi: 10.1128/aac.39.10.2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hsueh P. R., Chen H. M., Lu Y. C., Wu J. J. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc. 1996 Jan;95(1):29–36. [PubMed] [Google Scholar]
  8. Istre G. R., Welch D. F., Marks M. I., Moyer N. Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother. 1981 Aug;20(2):244–246. doi: 10.1128/aac.20.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leclercq R., Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 1991 Jul;35(7):1267–1272. doi: 10.1128/aac.35.7.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Libertin C. R., Leal F., Stein D. S. Group G Streptococci: susceptibility patterns and the effect of the inoculum size and growth phase on the bactericidal activity of penicillin. Diagn Microbiol Infect Dis. 1988 Jan;9(1):33–40. doi: 10.1016/0732-8893(88)90058-2. [DOI] [PubMed] [Google Scholar]
  11. Lämmler C., Schwarz S., Wibawan I. W., Ott E., Bopp V., Martinez-Tagle A. Comparison of streptococci of serological group B isolated from healthy carriers and active disease in Chile. J Med Microbiol. 1995 Mar;42(3):161–164. doi: 10.1099/00222615-42-3-161. [DOI] [PubMed] [Google Scholar]
  12. Phillips G., Parratt D., Orange G. V., Harper I., McEwan H., Young N. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother. 1990 Apr;25(4):723–724. doi: 10.1093/jac/25.4.723. [DOI] [PubMed] [Google Scholar]
  13. Potgieter E., Carmichael M., Koornhof H. J., Chalkley L. J. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):543–546. doi: 10.1007/BF01960811. [DOI] [PubMed] [Google Scholar]
  14. Rolston K. V., LeFrock J. L., Schell R. F. Activity of nine antimicrobial agents against Lancefield group C and group G streptococci. Antimicrob Agents Chemother. 1982 Nov;22(5):930–932. doi: 10.1128/aac.22.5.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Seppälä H., Nissinen A., Järvinen H., Huovinen S., Henriksson T., Herva E., Holm S. E., Jahkola M., Katila M. L., Klaukka T. Resistance to erythromycin in group A streptococci. N Engl J Med. 1992 Jan 30;326(5):292–297. doi: 10.1056/NEJM199201303260503. [DOI] [PubMed] [Google Scholar]
  16. Seppälä H., Nissinen A., Yu Q., Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother. 1993 Dec;32(6):885–891. doi: 10.1093/jac/32.6.885. [DOI] [PubMed] [Google Scholar]
  17. Stingemore N., Francis G. R., Toohey M., McGechie D. B. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med J Aust. 1989 Jun 5;150(11):626-7, 630-1. doi: 10.5694/j.1326-5377.1989.tb136725.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES